glp-1 receptor agonists in pediatric and adolescent obesity prescribing among teens with JAMA - Nearly 17 million
Description
Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic Z, Greig NH, Li Y, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ
For consumer goods companies, this represents both a challenge and an opportunity
doi: 10.1111/dom.15459 [DOI] [PubMed] [Google Scholar] 166.Di Stefano R, Rindi LV, Baldini V, et al
View at Publisher | View at Google Scholar Green BD et al
Check with your health insurance or your employer health program to see if it is covered
A novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits weight-lowering and diabetes-protective effects
